Avantax Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Avantax Advisory Services's DGX Position: Q2 2025 in Review
Avantax Advisory Services increased its Quest Diagnostics (DGX) stake by 4.8% in Q2 2025, buying an estimated $75.7K and bringing the position to 9,426 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #883.
Avantax Advisory Services first reported a position in DGX in Q2 2020 and has held it in 21 quarters since. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.
- Avantax Advisory Services held 9,426 shares of Quest Diagnostics worth $1.69M as of Q2 2025.
- Avantax Advisory Services bought 436 Quest Diagnostics shares in Q2 2025, an estimated $75.7K.
- Quest Diagnostics made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #883 holding.
- Avantax Advisory Services first reported a position in Quest Diagnostics in Q2 2020 and has held it in 21 quarters since.
- 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.